NDC 70594-117-01 - Bupivacaine HCl
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70594-117
- Requested NDC
- 70594-117-01
- Package NDCs from labels
- 70594-117-01, 70594-117-02
- Manufacturer
- Xellia Pharmaceuticals USA LLC
- Effective date
- 2023-06-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Bupivacaine HCl - Xellia Pharmaceuticals USA LLC | Xellia Pharmaceuticals USA LLC | 2023-06-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70594-117-01 | Bupivacaine HCl | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 2 | |
| 70594-117-02 | Bupivacaine HCl | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70594-117 | BUPIVACAINE HCL (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION BUPIVACAINE HCL (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION BUPIVACINE HCL (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [XELLIA PHARMACEUTICALS USA LLC] | 2 | Current NDC, 2 package rows | 20230622_f29c905e-9a55-446f-a89d-860ad9ade7ad.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70594-117-01 | ML - Milliliter | 70594-117 | 2feb9562-35c1-4637-931e-9f2fbd531c6a | 1 | 2023-08-08 |
| 70594-117-02 | ML - Milliliter | 70594-117 | 76e4c81c-6b22-4365-85ea-1c7bc2ea9661 | 1 | 2023-08-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SENSORCAINE | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Sportpharm LLC | 370f3e9f-5081-4b06-9cfb-de39f6bf6ca2 | 2026-08-31 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
| BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | NorthStar RxLLC | ee3b5bbe-4013-4682-b6ee-db86e7788077 | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | 1724880 1724884 1724787 1725078 1725082 1724786 7TQO7W3VT8 |
| Marcaine | BUPIVACAINE HYDROCHLORIDE | Henry Schein, Inc. | 562f4499-f3b7-4d9e-b022-61172176c883 | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | 1725078 7TQO7W3VT8 |
| Marcaine | BUPIVACAINE HYDROCHLORIDE | Henry Schein, Inc. | 2c6f9b85-e783-4ad4-a804-a0ff1a32ec2c | 2026-06-24 | Warnings, Adverse reactions | 1724880 7TQO7W3VT8 |
| Marcaine Spinal | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | Hospira, Inc. | 9679cc05-2f8a-4e88-53b5-6e9122c8b8c0 | 2026-06-23 | Warnings, Adverse reactions | 7TQO7W3VT8 |
| BUPIVACAINE HCl | BUPIVACAINE HCL | HF Acquisition Co LLC, DBA HealthFirst | e391f807-7699-6d82-e053-2a95a90ab641 | 2026-06-22 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
| Marcaine | BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | 67578b56-7540-487e-1fba-481255620e78 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | 1724880 1724884 1724787 1725078 1725082 1724786 7TQO7W3VT8 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Sportpharm LLC | 6f9ebeef-350a-495e-a0bf-c335ab48bf1c | 2026-04-24 | Boxed warning, Warnings, Adverse reactions | 1725078 7TQO7W3VT8 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Cardinal Health 107, LLC | 8f8f4ece-de78-4c13-8d9f-c3bb7053019d | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | 1725082 7TQO7W3VT8 |
| BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | bb44c7e1-d911-4788-908f-09b7b271969b | 2026-04-14 | Boxed warning, Warnings, Adverse reactions | 1725078 1725082 7TQO7W3VT8 |
| Bupivacaine Spinal | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | Hospira, Inc. | 7a8d2539-4422-4312-0298-207ef1a2948e | 2026-04-07 | Warnings, Adverse reactions | 7TQO7W3VT8 |
| BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | Camber Pharmaceuticals, Inc. | 0e552e3a-cf52-4d74-9381-6cc1b29b4c90 | 2026-04-04 | Boxed warning, Warnings, Adverse reactions | 1724880 1724884 1724787 1725078 1725082 1724786 7TQO7W3VT8 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | 02a845c3-4521-4926-e397-25ab536e7cf6 | 2026-03-09 | Boxed warning, Warnings, Adverse reactions | 1724880 1724884 1724787 1725078 1725082 1724786 7TQO7W3VT8 |
| Marlido Kit | MARCAINE, LIDOCAINE, POVIDONE IODINE | Advanced Rx of Tennessee, LLC | 49ef92f6-54d0-3d47-e063-6394a90aacec | 2026-01-30 | Boxed warning, Warnings, Adverse reactions | 1724880 |
| MARCAINE WITH EPINEPHRINE | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Henry Schein, Inc. | d0d51133-882c-4f9e-ba1c-f037226305a1 | 2026-01-28 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
| Marcaine | BUPIVACINE HYDROCHLORIDE | Henry Schein, Inc. | 7d94e8e0-0d1e-4af3-973a-a480d7d51737 | 2026-01-26 | Warnings, Adverse reactions | 1724884 7TQO7W3VT8 |
| Marvona-25 SUIK | BUPIVACAINE HYDROCHLORIDE | Asclemed USA, Inc. | cb71b757-057e-42d4-8a12-8fd8e69a9124 | 2026-01-23 | Boxed warning, Warnings, Adverse reactions | 7TQO7W3VT8 |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Brookfield Pharmaceuticals, LLC. | e8b32972-6984-4f1c-e053-2995a90a3277 | 2026-01-13 | Warnings, Adverse reactions | 7TQO7W3VT8 |
| Marbeta 25 Kit | BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE, BUPIVACAINE HYDROCHLORIDE, POVIDINE IODINE | Asclemed USA, Inc. | 1c157964-1977-4617-9f01-76ca01fb0f8f | 2026-01-10 | Boxed warning, Warnings, Adverse reactions | 1725078 |
| Dyural 40 Kit | METHYLPREDNISOLONE ACETATE, LIDOCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE, POVIDINE IODINE, SODIUM CHLORIDE, ISOPROPYL ALCOHOL | Asclemed USA, Inc. | 151ae26c-bd4e-4582-b67a-7b5baf466953 | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | 1725078 1725082 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.